Benzinga | Aug 6, 2020 09:01AM EDT

AMAG Pharmaceuticals Earlier Reported Q2 EPS $(0.39) Misses $(0.19) Estimate, Sales $52.80M Miss $57.95M Estimate

AMAG Pharmaceuticals (NASDAQ:AMAG) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.19) by 105.26 percent. This is a 65.79 percent increase over losses of $(1.14) per share from the same period last year. The company reported quarterly sales of $52.80 million which missed the analyst consensus estimate of $57.95 million by 8.89 percent. This is a 32.40 percent decrease over sales of $78.11 million the same period last year.